Concepedia

Publication | Open Access

Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis

80

Citations

30

References

2017

Year

Abstract

Our data indicate that vedolizumab could be an option in the treatment of patients with chronic, antibiotic-dependent or refractory pouchitis.

References

YearCitations

Page 1